- Monedas 17 129
- Exchanges 1 296
- Capitalización $2 596 481 963 467
- 24H Vol $121 572 020 515
- Dominio BTC 60.33% ETH 7.43%
Metformin (met) Gráfico en Vivo
| Rango | Nombre | Premios | Evolución (24h) | Suministro total | En circulación | |
|---|---|---|---|---|---|---|
| 6113 |
MET
Metformin
MET
| $ 0.00 | -14.36% | 999 884 686 | 999 884 686 | AI Insight |
Metformin (met)
Our team of three experienced medical doctors, with a strong track record of publications in high-impact SCI and SCI-Expanded journals, is embarking on an ambitious research project to investigate the longevity benefits of metformin. Metformin, widely recognized for its efficacy in managing type 2 diabetes, has drawn growing interest for its potential to influence aging and chronic disease pathways. Preclinical and clinical studies suggest that metformin may play a pivotal role in modulating mechanisms associated with aging, opening new avenues for research in longevity science.
Pares Disponibles
| Rango | Par | Nombre | Volumen (24h) | |
|---|---|---|---|---|
| 1 | 7W9GX1WBAYS6KNTD5OZDNNDS887YCBO4YSCJ66DUPUMP / SO11111111111111111111111111111111111111112 | Raydium | $ 1 358.13 | ¡Explora! |